BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan

  NLS Pharmaceutics Ltd. today announced that it is conducting an ongoing process to explore strategic alternatives to maximize shareholder value.

  November 16, 2023

   · 

  5 min read
• Biotech Bay

  Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR Kits for Sensitive Immune Repertoire Profiling

  Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR kits.

  November 16, 2023

   · 

  3 min read
• Business

  Renowned Nobel Laureate Jean-Marie Lehn Appointed Chairman of Syndivia’s Scientific Advisory Board

  Syndivia is excited to announce the appointment of Nobel Prize-winning chemist, Professor Jean-Marie Lehn , as the Chairman of the company’s Scientific Advisory Board (SAB).

  November 16, 2023

   · 

  2 min read
• Business

  SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments

  SHINE Technologies today announced a long-term supply agreement with Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals.

  November 16, 2023

   · 

  4 min read
• Deals

  Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

  Alzamend Neuro, Inc. today announced that it has received a notification letter (the “ Compliance Notice ”) from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC informing Alzamend that it has regained compliance with Nasdaq Listing Rule 5550(a)(2).

  November 16, 2023

   · 

  3 min read
• Drug Development

  Ensysce Biosciences Announces Enrollment Completion for PF614-201 Clinical Study

  Ensysce Biosciences, Inc. today announced that the PF614-201 study, & A Randomized, Double-Blind, Placebo-Controlled Crossover Study of PF614 on Analgesic Response in the Cold Pressor Test in Healthy Male Subjects’ has completed enrollment.

  November 16, 2023

   · 

  5 min read
• The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros

  Northway Group is embarking on a project to establish Europe’s largest biotechnology hub, BIO CITY, in Vilnius, the capital of Lithuania. It includes 6 large biotechnological complexes

  November 16, 2023

   · 

  5 min read
• Genetown

  Fractyl Health Expands Landmark Academic-Industry Collaboration to Study Mechanisms Underlying GLP-1-Based Pancreatic Gene Therapy for Type 2 Diabetes and Obesity

  Fractyl Health announced the expansion of an academic-industry scientific partnership charged with advancing research on the role of the gut and pancreas in metabolic disease.

  November 16, 2023

   · 

  4 min read
• Business

  Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

  Carmell Corporation (Nasdaq: CTCX), a human biomaterials company (“Carmell”), today announced the addition of two independent directors to their Board.

  November 16, 2023

   · 

  4 min read
• Biotech Bay

  Biomea Fusion Abstract Selected as One of Six Oral Presentations at 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease

  Biomea Fusion Inc. today announced that it has been selected for the 2023 oral session of the 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) taking place on December 7-9, following previous poster acceptance.

  November 16, 2023

   · 

  6 min read